by Mike Masnick
Mon, Mar 26th 2012 8:03pm
As we expected, following the Supreme Court's excellent rejection of medical diagnostic patents, it's now set aside the appeals court's ruling upholding gene patents, and asked the appeals court to review the case in light of its ruling last week. Again, this is not a surprise, but it's good that the court so quickly recognized that the two cases have similar issues, and that the appeals court ought to revisit the Myriad (gene patents) ruling so quickly. Hopefully, CAFC (the appeals court in question) will come to its senses and recognize that you can't patent genes. Either way, no matter what CAFC decides, expect that to also be appealed right back to the Supreme Court.
If you liked this post, you may also be interested in...
- Antitrust Suit Alleges Pharma Company Rubbished Its Own Product In Order To Stave Off Competition From Generics
- FTC Releases Big Report On Patent Trolls, Says The Patent System Needs To Change
- Prominent Pro-Patent Judge Issues Opinion Declaring All Software Patents Bad
- Myriad Genetics Refuses To Accept That People Have A Right To Access Their Own DNA Sequences
- Australia Finally Rejects Gene Patents